Zim Laboratories Balance Sheet
- Market cap
- ₹756 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹101.70 – ₹190.69
As of FY25, Zim Laboratories had total assets of ₹491 crore and borrowings of ₹90.68 crore, against shareholders' equity of ₹460 crore — a debt-to-equity ratio of 0.35.
Zim Laboratories balance sheet
As at each financial year end, newest first. H1 = half-year.
| Item | FY25 |
|---|---|
| Equity capital | 120 |
| Reserves | 340 |
| Borrowings | 90.68 |
| Other liabilities | 60.46 |
| Total liabilities | 491 |
| Fixed assets | 264 |
| Capital work in progress | 45 |
| Investments | 113 |
| Other assets | 113 |
| Total assets | 491 |
Balance sheet ratios
- Debt to equity
- 0.35
- Book value per share
- ₹49.56
Source: Company filings (consolidated), in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Zim Laboratories balance sheet — frequently asked questions
What is the total debt of Zim Laboratories?
Zim Laboratories reported borrowings of ₹90.68 crore as of FY25.
What is Zim Laboratories' debt-to-equity ratio?
Based on the FY25 balance sheet, Zim Laboratories' debt-to-equity ratio is 0.35 — borrowings of ₹90.68 crore against equity capital and reserves of ₹460 crore.
What are Zim Laboratories' total assets?
Zim Laboratories' total assets were ₹491 crore as of FY25, including fixed assets of ₹264 crore and investments of ₹113 crore.
What is the book value per share of Zim Laboratories?
The book value per share of Zim Laboratories is ₹49.56, based on the latest reported balance sheet.
Same Data For Peers
Trade Zim Laboratories With ATS
Track ZIMLAB live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.